Stem cell science v. hype (start time: 00:57) Clinics offering stem cell therapies and other forms of so-called regenerative medicine are cropping up in many states, including Colorado. Practitioners of stem cells, are touting them as repairing damaged cartilage, tendons and joints, and even treating diseases such as Parkinson’s and Alzheimer’s. While the science looks promising, it seriously lags the marketing of stem cell therapies. Last year the FDA, which has yet to regulate the clinics, issued a warning about stem cell therapies. Laura Beil, a science journalist and producer of the podcast Bad Batch, recently wrote a cover article in Science News about the hype and the latest science of stem cells. She talks with host Susan Moran about her reporting. (For more info, check out this new BBC program on stem cell “hope and hype.”)
Science for the Rest of Us (start time: 16:38) At a time our own government leaders vilify science and reinvent facts, it seems as important as ever that journalists and the public at large grasp and translate scientific research. A new book, The Craft of Science Writing, offers tips on how to find credible experts (whether on the corona virus or vaccines or climate change), separate truth from spurious assertions, and make sense of scientific studies. The book is aimed at science writers, but it can be a guidepost for anyone who wants to make science more accessible. Alex Witze, a science writer who co-authored the book Island On Fire: The Extraordinary Story of a Forgotten Volcano, is a contributor to the new book. She discusses the art of decoding and appreciating science with hosts Susan Moran and Joel Parker.
Hosts: Susan Moran, Joel Parker Producer: Susan Moran Engineer: Joel Parker Executive Producer: Beth Bennet
A Consumer’s Guide to Pesticides in Produce (starts 7:55) You may be wondering if you washed the strawberries, blueberries or kale that you had for breakfast this morning enough to rid them of residue of potentially harmful pesticides. That is, if they were conventionally, not organically, grown. According to the U.S. Department of Agriculture, more than 200 different pesticides remain in some form on popular fruits and vegetables that Americans eat every day. And before testing all the produce, the USDA thoroughly washes and peels them. Such tests show that simply washing produce does not remove all pesticides. In a recently released report, as part of its “Shopper’s Guide to Pesticides in Produce,”The Environmental Working Group ranked the pesticide contamination of 47 popular fruits and vegetables. Its analysis, which was based on results of nearly 50,000 samples of produce that the USDA tested, found that 70 percent of produce contains pesticide residues. But don’t despair: There is also good news in the report. Sydney Evans, a science analyst at EWG, and Liza Gross, an independent investigative reporter, speak with host Susan Moran about the EWG report and the broader societal and environmental implications of pesticides. See Liza Gross’ articles on pesticides and other issues.
Hosts: Maeve Conran, Susan Moran Producer: Susan Moran Engineer: Maeve Conran Additional Contributors: Chip Grandits, Beth Bennett, Gretchen Wettstein Executive Producer: Joel Parker
Regenerative Medicine (start time: 7:30): We begin our series on regenerative medicine with a discussion of scientific advancements, promises, caveats, regulations, and challenges of regenerative medicine therapies for orthopedic applications, such as stem cell, prolo therapy and PRP (platlet-rich plasma) therapy. Together, these therapies aim to regenerate or replace injured, diseased, or defective cells, tissues, or organs with the goal of restoring or establishing function and structure. Hosts Susan Moran and Beth Bennett interview Jason Glowney, MD, founder of Boulder Biologics, which focuses on regenerative and integrative medicine.
Hosts: Beth Bennett, Susan Moran Producer: Susan Moran Engineer: Beth Bennett Executive Producer: Susan Moran
This week on How on Earth host Susan Moran interviews two investigators of FDA-approved clinical trials testing the efficacy and safety of the illegal drug MDMA — known in an altered form as Ecstasy or Molly — as a treatment (along with psychotherapy sessions) for Post-Traumatic Stress Syndrome. Our guests are Marcela Ot’alora and Bruce Poulter, investigators of the Colorado trial. Marcela is a licensed psychotherapist and Bruce is a registered nurse with a masters degree in public health
PTSD is an anxiety disorder that affects up to one in 12 people in the United States, and it’s at least as common in some other countries. It is a serious, and costly, public health problem. If the trials are successful, MDMA, which has its critics, could become commercially available as a medically prescribed treatment by 2021. The trials are being funded by a nonprofit organization, the Multidisciplinary Association for Psychedelic Studies (MAPS), which promotes careful and beneficial uses of psychedelics and marijuana.
Hosts: Susan Moran, Joel Parker Producer: Susan Moran Engineer: Joel Parker Executive Producer: Joel Parker